Early diabetes drug test focuses on kidney safety
NCT ID NCT01512849
Summary
This early-stage study tested how a diabetes medication called TA-7284 works in people with type 2 diabetes who also have moderate kidney problems. Researchers compared 24 participants with kidney issues to those with normal kidney function to see how the drug is processed by the body and its safety. The study measured drug levels in blood and urine, and monitored for side effects over a short period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Reserch site
Kanto, Japan
Conditions
Explore the condition pages connected to this study.